A new artificial tool is underway at Shaare Zedek Medical Center in Jerusalem, and it is sure to conquer the world of medicine!
Shaare Zedek Oncology experts developed an artificial intelligence (AI)-based system that will improve the treatment of Lung Cancer. The new innovative tool under development can predict the effects of Immunotherapy on patients suffering from Lung Cancer. The AI -based technology, named I3LUNG, will make use of the machine and deep learning to analyze a wide variety of patient information, in order to formulate a treatment plan that is best suited to the specific medical situation of every patient, which will save hundreds of Lung Cancer patients—Lung Cancer is the leading cause of death from Cancer in men, and second among women.
The development of the new innovation is funded by a grant from the prestigious European Union’s Horizon 2020 program, which Israel joined in 2021.
Shaare Zedek was chosen to become the first and only Israeli hospital to receive such a grant. The goal, the medical center says, is to create a new tool to improve the Lung Cancer decision-making process by medical staff through a novel and innovative AI and deep learning technology that will predict the response to Immunotherapy.
As part of the research done on the project, Oncology experts from Italy, Germany, Spain, Greece, and the United States, as well as staff from Shaare Zedek’s oncology department, all joined the effort to begin the development of the groundbreaking tool.
The I3LUNG project is headed by Shaare Zedek’s Oncology Department Head Prof. Nir Peled ,and Dr. Laila Roisman, Head of Shaare Zedek’s Cancer Research Innovation Department.
Roisman explained that the information gathered by I3LUNG will come from a retrospective analysis of 2,000 Lung Cancer patients from Oncology departments across the globe.
“Soon, Shaare Zedek patients will have an option to be part of a new technological breakthrough in terms of personalizing Cancer treatment,” Roisman said.
Prof. Peled summarized that “it is a big honour to be part of this medical revolution, which is a credit to Israel.”